Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$899K Sell
6,995
-2,025
-22% -$237K 0.11% 128
2026
Q1
$1.09M Sell
9,020
-1,124
-11% -$130K 0.15% 116
2025
Q4
$1.07M Sell
10,144
-2,673
-21% -$251K 0.14% 119
2025
Q3
$1.08M Sell
12,817
-260
-2% -$21.4K 0.14% 125
2025
Q2
$1.04M Sell
13,077
-249
-2% -$19.8K 0.15% 123
2025
Q1
$1.2M Sell
13,326
-1,486
-10% -$139K 0.19% 105
2024
Q4
$1.47M Sell
14,812
-1,327
-8% -$137K 0.22% 95
2024
Q3
$1.83M Buy
16,139
+2,584
+19% +$307K 0.28% 87
2024
Q2
$1.68M Sell
13,555
-488
-3% -$62.9K 0.3% 80
2024
Q1
$1.85M Buy
14,043
+222
+2% +$27.4K 0.35% 72
2023
Q4
$1.51M Buy
13,821
+30
+0.2% +$3.11K 0.31% 79
2023
Q3
$1.42M Sell
13,791
-69
-0.5% -$7.44K 0.35% 72
2023
Q2
$1.6M Sell
13,860
-275
-2% -$31.2K 0.38% 66
2023
Q1
$1.5M Buy
14,135
+768
+6% +$82.9K 0.38% 69
2022
Q4
$1.48M Buy
13,367
+24
+0.2% +$2.45K 0.41% 69
2022
Q3
$1.15M Buy
+13,343
New +$1.19M 0.37% 75

Other funds holding MRK

Colonial Trust's MRK Position: Q2 2026 in Review

Colonial Trust reduced its Merck (MRK) stake by 22% in Q2 2026, selling an estimated $237K and leaving 6,995 shares worth $899K. The position accounts for 0.11% of the portfolio, ranked #128.

Colonial Trust first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.85M in Q1 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Colonial Trust held 6,995 shares of Merck worth $899K as of Q2 2026.
  • Colonial Trust sold 2,025 Merck shares in Q2 2026, an estimated $237K.
  • Merck made up 0.11% of Colonial Trust's portfolio in Q2 2026, its #128 holding.
  • Colonial Trust first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's Merck position peaked at $1.85M in Q1 2024.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.